The Role of Sonographic Markers of Ovarian Morphology Versus Hirsutism Indices in the Prediction of Serum Total Testosterone in Hirsute Women
Journal Title: Open Access Journal of Reproductive System and Sexual Disorders - Year 2018, Vol 1, Issue 2
Abstract
Objective: To evaluate the role of sonographic markers of ovarian morphology versus hirsutism indices in the prediction of serum total testosterone in hirsute women. Study Design: Cross sectional observational Study. Subjects: Eighty women (aged 18 to 40 years) form among the attendants of the Gynecology Clinic of Minia University Hospital complaining of hirsutism were recruited into the Study in the period between January and May 2017 after obtaining their informed consent.Participants were evaluated regarding self-reported menstrual cycle history to determine the extent of any menstrual cycle disturbance; male-pattern hair growth was assessed on nine regions of the body using the modified Ferriman-Gallwey (mFG) scoring system, a transvaginal ultrasound scan to characterize ovarian morphology and fasting blood sample for testosterone assay. Main Outcome Measures: Regional and total modified Ferriman-Gallwey (mFG) scores, number of follicles per follicle size category, follicle number per ovary (FNPO), ovarian volume (OV), ovarian area (OA), stromal to ovarian area ratio (S/A), stromal echogenicity index (SI), total testosterone (TT) and menstrual cycle length. Results: There were no correlations between any of the demographic characteristics of the study participants and total testosterone.There were no correlations between hirsutism scores and total testosterone of all study participants. However, there were some association between hirsutism scores (upper lip, chin and lower abdomen) and total testosterone of all study participants.
Authors and Affiliations
Dina Hisham Hussain Emam Abdallah, Mohamed Tawfik Gad Al-Rab, Emad Mossa Ibrahim, Momen Mohamed Hassan, Ayman Moheb, Essia Mahmod Khalefia, Nashwa Mohamed Adel, Mostafa Ahmed El Sayed
Schistosomahaematobium and Urogenital Disorders
Concerning Europe, we are in the presence of a re-introduction of this disease, since it had been recorded in Portugal, where several foci had occurred in Algarve-Southern Portugal [2,3] Still in Euro...
Challenges in the Treatment of Vasomotor Symptoms:Update in Non-Hormonal Strategies
Perimenopause and menopause per se significantly impacts on women quality of life (QoL), especially due to vasomotor symptoms (VMS); their duration is uncertain, and often long. Although menopause hormone therapy (MHT) i...
Nonmosaic Klinefelter Syndrome Successful Conception after TESE/ICSI: A case report
Klinefelter syndrome patients are mostly clinically azoospermic, and before the era of TESE, were unable to father genetically their own offspring. Nonmosaic Klinefelter [NMK] patients have chances of fatherhood once spe...
Genito Urinary Syndrome of Menopause “A New Terminology for an Ever-Present Symptomatology”
The genitourinary syndrome is a chronic and progressive entity characterized by symptoms such as vaginal irritation, burning, dryness, dyspareunia, dysuria and urinary urgency that affect the quality of life of most post...
Luteal Phase Support using Oral Dydrogesterone-a Prospective Treatment for Future Replacing Micronized Vaginal Progesterone
Although micronized vaginal progesterone is the accepted norm for use in luteal phase support (LPS) in controlled ovarian stimulation (COS) that is used for in vitro fertilization (IVF) cycles, recently...